---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-100468"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:29:21.073351+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Theriva (TOVX) raises ~$4.4M via warrant exercise at $0.54/share; grants 16.2M new warrants

## Summary
- Entered warrant inducement with existing holders exercising 8,092,280 shares at $0.54 for ~$4.4M gross proceeds.
- Issued new warrants for 16,184,560 shares (200% of exercised) at same $0.54 exercise price, exercisable 5 years from stockholder approval.
- Net proceeds will be used for working capital; AGP served as financial advisor with 7% cash fee.
- New warrants and underlying shares issued in private placement under Section 4(a)(2); resale registration to be filed within 30 days.
- Company must seek stockholder approval for exercise of new warrants; meetings every 60 days if not obtained.

## SEC filing metadata
- accession: 0001104659-25-100468
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/0001104659-25-100468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465925100468/tm2528131d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-100468
- JSON: https://secwatch.observer/filing/0001104659-25-100468.json
- Plain text: https://secwatch.observer/filing/0001104659-25-100468.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.